Lysergic acid morpholide

Orders received during 11/25~11/29 will be shipped in 11/30/2020 due to Thanksgiving holiday.

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 599277

CAS#: 4314-63-0

Description: Lysergic acid morpholide is discontinued (DEA controlled substance). Lysergic acid morpholide is a stimulant drug.

Price and Availability

Size Price Shipping out time Quantity
Inquire bulk and customized quantity

Pricing updated 2020-11-29. Prices are subject to change without notice.

Lysergic acid morpholide is discontinued (DEA controlled substance).

Chemical Structure


Theoretical Analysis

MedKoo Cat#: 599277
Name: Lysergic acid morpholide
CAS#: 4314-63-0
Chemical Formula: C20H23N3O2
Exact Mass: 337.179
Molecular Weight: 337.42
Elemental Analysis: C, 71.19; H, 6.87; N, 12.45; O, 9.48

Synonym: Lysergic acid morpholide; LSM-775; LSM 775; LSM775;

IUPAC/Chemical Name: ((6aR,9R)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinolin-9-yl)(morpholino)methanone


InChi Code: InChI=1S/C20H23N3O2/c1-22-12-14(20(24)23-5-7-25-8-6-23)9-16-15-3-2-4-17-19(15)13(11-21-17)10-18(16)22/h2-4,9,11,14,18,21H,5-8,10,12H2,1H3/t14-,18-/m1/s1

SMILES Code: [H][C@@]1(N(C)C[C@H](C(N2CCOCC2)=O)C=C13)CC4=CNC5=C4C3=CC=C5

Technical Data

Solid powder

>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Soluble in DMSO

Shelf Life:
>3 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:


1: GOGERTY JH, DILLE JM. Pharmacology of d-lysergic acid morpholide (LSM). J Pharmacol Exp Ther. 1957 Jul;120(3):340-8. PubMed PMID: 13476356.

2: Holliday AR. The effect of d-lysergic acid morpholide upon pain sensitivity. Proc West Pharmacol Soc. 1966;9:57-9. PubMed PMID: 5334995.

3: Brandt SD, Kavanagh PV, Twamley B, Westphal F, Elliott SP, Wallach J, Stratford A, Klein LM, McCorvy JD, Nichols DE, Halberstadt AL. Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775). Drug Test Anal. 2018 Feb;10(2):310-322. doi: 10.1002/dta.2222. Epub 2017 Jul 27. PubMed PMID: 28585392.